While factors like genetics and age are fixed, you can take control of several modifiable risk factors to help prevent or ...

A new study published in The Lancet Obstetrics, Gynaecology and Women's Health has found that women with polyendocrine ...

GLP-1 drugs such as Wegovy and Ozempic have been revolutionary for obesity and type 2 diabetes treatments, but questions ...

Weight loss and diabetes drugs such as Mounjaro, Ozempic and Wegovy are linked to an increased risk of hair loss, researchers ...

Up to 45 per cent of dementia risk may be linked to factors that can be modified or managed, prompting the World Health ...

They said rapid weight loss was a well-established trigger of hair shedding and can also lead to iron or zinc deficiencies, ...

Weight loss drugs such as Mounjaro, Ozempic and Wegovy are linked to an increased risk of hair loss, according to researchers ...

The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an ...

One group of women in the United States is at a much higher risk of heart disease, a new nationwide study has suggested.

Young women are leading a worrying increase in early-onset type 2 diabetes diagnoses in England, according to a new analysis.

Most people think that heart disease is a problem that develops later in life. However, certain health conditions during the ...

On World Brain Day, experts say protecting brain health starts long before symptoms appear, with lifestyle choices playing a ...